An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.
The $1.6bn fundraise more than doubled the fund’s target size of $750m. The mid-market strategy will focus on the technology, services and healthcare sectors, prioritising India, SE Asia, Japan and Australia.
The manufacturing facility, supported by Singapore's Economic Development Board, is for antibody drug conjugates, and will be designed to be "zero carbon" from its first day of operation in 2029.
Pariyapol Kamolsilp will join the law firm on May 2 in Bangkok, while six lawyers, based in Bangkok, Hong Kong, Singapore and Tokyo, have been promoted to counsel.
SEA’s net zero transition will be challenging due to the region's heavy reliance on fossil fuels and rising energy needs. CEOs from DBS and the Energy Market Authority, shared their views on the strategies for a "win-win" of economic growth and a just transition, at Ecosperity Week 2024.
The bank wants to help scale digital 'platform players', and is also offering $150m of venture debt to the Singapore market to provide financing to early-stage, high-growth companies backed by venture capital or private equity.
Artificial intelligence (AI) was the big stock story of 2023. Christopher Chu asked experts about how AI is likely to perform as an investment opportunity in 2024.